CVS Health Corporation (NYSE:CVS) announced a quarterly dividend on Thursday, September 22nd. Stockholders of record on Monday, October 24th will be given a dividend of 0.425 per share by the pharmacy operator on Thursday, November 3rd. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date is Thursday, October 20th.

Shares of CVS Health Corporation (NYSE:CVS) opened at 88.80 on Friday. The stock has a 50 day moving average of $90.11 and a 200-day moving average of $96.45. The company has a market capitalization of $94.68 billion, a PE ratio of 20.43 and a beta of 0.83. CVS Health Corporation has a 12-month low of $85.41 and a 12-month high of $106.67.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The company had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. During the same quarter in the prior year, the company posted $1.19 earnings per share. CVS Health Corporation’s revenue for the quarter was up 17.6% compared to the same quarter last year. Analysts predict that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

Dividend History for CVS Health Corporation (NYSE:CVS)

A number of research firms have commented on CVS. Deutsche Bank AG upped their target price on shares of CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research report on Wednesday, June 22nd. Argus reiterated a “buy” rating and set a $120.00 price target on shares of CVS Health Corporation in a research note on Thursday, August 4th. Leerink Swann reiterated a “buy” rating on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Zacks Investment Research upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, August 3rd. Finally, Mizuho boosted their price target on shares of CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Five research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $112.40.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Argent Trust Co boosted its position in CVS Health Corporation by 3.5% in the second quarter. Argent Trust Co now owns 15,209 shares of the pharmacy operator’s stock valued at $1,456,000 after buying an additional 521 shares during the last quarter. Columbia Partners L L C Investment Management boosted its position in CVS Health Corporation by 1.3% in the second quarter. Columbia Partners L L C Investment Management now owns 31,254 shares of the pharmacy operator’s stock valued at $2,992,000 after buying an additional 391 shares during the last quarter. Highlander Capital Management LLC boosted its position in CVS Health Corporation by 38.1% in the second quarter. Highlander Capital Management LLC now owns 2,900 shares of the pharmacy operator’s stock valued at $278,000 after buying an additional 800 shares during the last quarter. Beaumont Financial Partners LLC boosted its position in CVS Health Corporation by 18.4% in the second quarter. Beaumont Financial Partners LLC now owns 60,312 shares of the pharmacy operator’s stock valued at $5,774,000 after buying an additional 9,393 shares during the last quarter. Finally, IPG Investment Advisors LLC boosted its position in CVS Health Corporation by 8.3% in the second quarter. IPG Investment Advisors LLC now owns 6,500 shares of the pharmacy operator’s stock valued at $622,000 after buying an additional 500 shares during the last quarter. Hedge funds and other institutional investors own 80.95% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.